Rigel Pharmaceuticals (RIGL) Financials: Revenue & Earnings
$948.09M
Market Cap
—
P/E
—
Forward P/E
—
Score
RIGL price $50.75 +0.20 +0.40%
RIGL fair value $121.97. Price $50.75. Price is 58% below fair value.
Below fair value, but more expensive than usual. A smaller discount than on more than 99% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 28.66M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.83% (beta 1.2). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 18.68M. Net debt 12.72M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-03 | — | 0.92 | — | 80.10M |
| 2026-08-04 | 0.88 | 0.09 | 78.70M | 55.27M |
| 2026-05-05 | 0.44 | 0.74 | 58.82M | 62.40M |
| 2026-03-03 | 1.14 | 1.33 | 69.80M | 68.70M |
| 2025-11-04 | 1.46 | 0.93 | 69.46M | 68.42M |
| 2025-08-05 | 3.28 | 1.97 | 101.69M | 62.31M |
| 2025-05-06 | 0.63 | 0.14 | 53.33M | 48.32M |
| 2025-03-04 | 0.80 | 0.30 | 57.60M | 57.59M |
| 2024-11-07 | 0.70 | 0.06 | 55.31M | 47.42M |
| 2024-08-06 | -0.06 | -0.37 | 36.84M | 33.42M |
| 2024-05-07 | -0.50 | -0.30 | 29.53M | 31.28M |
| 2024-03-05 | 0.04 | 0.02 | 35.79M | 34.10M |
| 2023-11-07 | -0.30 | -0.70 | 28.13M | 29.78M |
| 2023-08-01 | -0.40 | -0.80 | 26.89M | 25.70M |
| 2023-05-02 | -0.80 | -0.90 | 26.07M | 24.07M |
| 2023-03-07 | 0.10 | -0.70 | 51.28M | 36.52M |
| 2022-11-03 | -1.10 | -1.30 | 22.41M | 22.61M |
| 2022-08-02 | -0.80 | -1.20 | 29.82M | 23.65M |
| 2022-05-03 | -1.60 | -0.14 | 16.73M | 17.58M |
| 2022-03-01 | -1.30 | -1.30 | 20.41M | 21.90M |
| 2021-11-02 | -1.20 | -1.00 | 21.54M | 23.56M |
| 2021-08-03 | -0.80 | -1.10 | 26.27M | 20.37M |
| 2021-05-05 | 2.20 | 0.10 | 81.02M | 1.46B |
| 2021-03-02 | -1.10 | -1.00 | 18.45M | — |
| 2020-11-05 | -0.80 | -1.20 | 18.39M | 27.58M |
| 2020-08-04 | -1.00 | -1.30 | 16.02M | 20.83M |
| 2020-05-05 | 1.30 | 1.30 | 55.76M | 55.76M |
| 2020-02-27 | -1.00 | -1.10 | 15.40M | 12.32M |
| 2019-11-05 | -0.70 | -1.10 | 20.86M | 32.78M |
| 2019-08-06 | -1.20 | -1.40 | 10.41M | 12.14M |
| 2019-05-07 | -1.10 | -1.30 | 12.62M | 14.92M |
| 2019-02-28 | 0.20 | 0.30 | 37.86M | 37.86M |
| 2018-11-06 | -1.40 | -1.60 | 4.87M | 5.21M |
| 2018-08-08 | -1.60 | -1.60 | 1.79M | 1.79M |
| 2018-05-01 | -1.70 | -1.70 | — | — |
| 2018-03-06 | -1.80 | -1.30 | — | — |
| 2017-11-07 | -1.40 | -1.50 | 900.00K | 964.29K |
| 2017-08-01 | -1.60 | -1.50 | — | — |
| 2017-05-02 | -1.30 | -1.20 | 3.58M | 3.30M |
| 2017-03-07 | -1.60 | -2.10 | 3.00M | 3.19M |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Schorno Dean L | Buy | 1.29K | $24.20 | 31.12K |
| 2026-09-02 | Schorno Dean L | Buy | 2.00K | $24.20 | 48.40K |
| 2026-09-02 | Schorno Dean L | Buy | 620 | $18.70 | 11.59K |
| 2026-09-02 | Schorno Dean L | Buy | 694 | $12.70 | 8.81K |
| 2026-09-02 | Schorno Dean L | Sell | 1.29K | $24.20 | 31.12K |
| 2026-09-02 | Schorno Dean L | Sell | 694 | $12.70 | 8.81K |
| 2026-09-02 | Schorno Dean L | Sell | 620 | $18.70 | 11.59K |
| 2026-09-02 | Schorno Dean L | Sell | 2.00K | $24.20 | 48.40K |
| 2026-09-01 | Schorno Dean L | Sell | 928 | $47.50 | 44.08K |
| 2026-09-01 | Santos David A | Sell | 874 | $47.50 | 41.52K |
| 2026-09-01 | RODRIGUEZ RAUL R | Sell | 2.42K | $47.50 | 115.14K |
| 2026-09-01 | Furey Raymond J. | Sell | 877 | $47.50 | 41.66K |
| 2026-07-08 | HANNAH ALISON L. | Buy | 24.40K | — | — |
| 2026-06-22 | Ali-Jackson Kamil | Sell | 2.50K | $35.00 | 87.50K |
| 2026-06-17 | Furey Raymond J. | Buy | 7.39K | $22.49 | 166.29K |
| 2026-06-17 | RODRIGUEZ RAUL R | Buy | 31.70K | $22.49 | 712.93K |
| 2026-06-17 | Rojkjaer Lisa | Buy | 9.38K | $14.90 | 139.69K |
| 2026-06-17 | Rojkjaer Lisa | Buy | 7.39K | $22.49 | 166.29K |
| 2026-06-17 | Santos David A | Buy | 7.39K | $22.49 | 166.29K |
| 2026-06-17 | Schorno Dean L | Buy | 7.39K | $22.49 | 166.29K |
| 2026-06-01 | Schorno Dean L | Buy | 2.18K | $12.70 | 27.70K |
| 2026-06-01 | Schorno Dean L | Sell | 928 | $29.86 | 27.71K |
| 2026-06-01 | Schorno Dean L | Buy | 1.20K | $18.70 | 22.44K |
| 2026-06-01 | Schorno Dean L | Sell | 2.18K | $12.70 | 27.70K |
| 2026-06-01 | Schorno Dean L | Sell | 1.20K | $18.70 | 22.44K |
| 2026-06-01 | Santos David A | Sell | 874 | $29.86 | 26.10K |
| 2026-06-01 | Rojkjaer Lisa | Sell | 850 | $29.86 | 25.38K |
| 2026-06-01 | RODRIGUEZ RAUL R | Sell | 2.42K | $29.86 | 72.38K |
| 2026-06-01 | Furey Raymond J. | Sell | 877 | $29.86 | 26.19K |
| 2026-05-26 | Ali-Jackson Kamil | Sell | 2.50K | $29.17 | 72.92K |
| 2026-05-15 | Wasman Jane | Buy | 5.75K | — | — |
| 2026-05-15 | MOOS WALTER H | Buy | 5.75K | — | — |
| 2026-05-15 | MILLER MICHAEL PATRICK | Buy | 5.75K | — | — |
| 2026-05-15 | LAPOINTE ANTHONY GREGG | Buy | 5.75K | — | — |
| 2026-05-15 | HANNAH ALISON L. | Buy | 5.75K | — | — |
| 2026-05-15 | Frohlich Mark W | Buy | 5.75K | — | — |
| 2026-05-15 | Ali-Jackson Kamil | Buy | 5.75K | — | — |
| 2026-02-20 | MOOS WALTER H | Buy | 4.00K | $24.00 | 96.00K |
| 2026-02-20 | MOOS WALTER H | Sell | 4.00K | $36.36 | 145.44K |
| 2026-02-20 | MOOS WALTER H | Sell | 4.00K | $24.00 | 96.00K |
| 2026-02-17 | Furey Raymond J. | Buy | 19.50K | — | — |
| 2026-02-17 | RODRIGUEZ RAUL R | Buy | 53.91K | — | — |
| 2026-02-17 | Rojkjaer Lisa | Buy | 18.89K | — | — |
| 2026-02-17 | Schorno Dean L | Buy | 20.64K | — | — |
| 2026-02-17 | Santos David A | Buy | 19.43K | — | — |
| 2026-02-10 | Schorno Dean L | Sell | 3.55K | $34.62 | 122.76K |
| 2026-02-10 | Furey Raymond J. | Sell | 3.55K | $34.62 | 122.76K |
| 2026-02-10 | Santos David A | Sell | 3.55K | $34.62 | 122.76K |
| 2026-02-10 | RODRIGUEZ RAUL R | Sell | 7.61K | $34.62 | 263.35K |
| 2026-02-10 | Rojkjaer Lisa | Sell | 3.76K | $34.62 | 130.10K |
| 2026-02-02 | Santos David A | Sell | 5.72K | $36.01 | 205.91K |
| 2026-02-02 | Schorno Dean L | Sell | 5.49K | $36.01 | 197.62K |
| 2026-02-02 | Furey Raymond J. | Sell | 3.97K | $36.01 | 142.89K |
| 2026-02-02 | RODRIGUEZ RAUL R | Sell | 14.11K | $36.01 | 508.10K |
| 2026-02-01 | MILLER MICHAEL PATRICK | Buy | 12.00K | $34.86 | 418.32K |
| 2026-02-01 | MILLER MICHAEL PATRICK | Other | 0 | — | — |
| 2026-02-01 | MILLER MICHAEL PATRICK | Other | 625 | $16.05 | 10.03K |
| 2026-01-26 | RODRIGUEZ RAUL R | Buy | 40.00K | $27.40 | 1.10M |
| 2026-01-26 | RODRIGUEZ RAUL R | Buy | 40.00K | $27.40 | 1.10M |
| 2026-01-26 | RODRIGUEZ RAUL R | Sell | 35.42K | $37.00 | 1.31M |
| 2026-01-26 | RODRIGUEZ RAUL R | Sell | 35.21K | $37.00 | 1.30M |
| 2026-01-26 | RODRIGUEZ RAUL R | Sell | 40.00K | $27.40 | 1.10M |
| 2025-12-22 | Schorno Dean L | Buy | 1.67K | $18.70 | 31.17K |
| 2025-12-22 | Schorno Dean L | Buy | 2.85K | $24.20 | 68.87K |
| 2025-12-22 | Schorno Dean L | Buy | 1.99K | $20.00 | 39.74K |
| 2025-12-22 | Schorno Dean L | Sell | 2.85K | $24.20 | 68.87K |
| 2025-12-22 | Schorno Dean L | Sell | 1.99K | $20.00 | 39.74K |
| 2025-12-22 | Schorno Dean L | Sell | 1.67K | $18.70 | 31.17K |
| 2025-09-15 | Schorno Dean L | Buy | 7.39K | $22.49 | 166.29K |
| 2025-09-15 | Santos David A | Buy | 7.39K | $22.49 | 166.29K |
| 2025-09-15 | Rojkjaer Lisa | Buy | 7.39K | $22.49 | 166.29K |
| 2025-09-15 | Furey Raymond J. | Buy | 7.39K | $22.49 | 166.29K |
| 2025-09-15 | RODRIGUEZ RAUL R | Buy | 31.70K | $22.49 | 712.93K |
| 2025-05-23 | Wasman Jane | Buy | 2.50K | — | — |
| 2025-05-23 | Wasman Jane | Buy | 3.00K | $18.95 | 56.85K |
| 2025-05-23 | Ali-Jackson Kamil | Buy | 2.50K | — | — |
| 2025-05-23 | Ali-Jackson Kamil | Buy | 3.00K | $18.95 | 56.85K |
| 2025-05-23 | MOOS WALTER H | Buy | 2.50K | — | — |
| 2025-05-23 | MOOS WALTER H | Buy | 3.00K | $18.95 | 56.85K |
| 2025-05-23 | LAPOINTE ANTHONY GREGG | Buy | 2.50K | — | — |
| 2025-05-23 | LAPOINTE ANTHONY GREGG | Buy | 3.00K | $18.95 | 56.85K |
| 2025-05-23 | HANNAH ALISON L. | Buy | 2.50K | — | — |
| 2025-05-23 | HANNAH ALISON L. | Buy | 3.00K | $18.95 | 56.85K |
| 2025-05-23 | Frohlich Mark W | Buy | 1.50K | $18.95 | 28.43K |
| 2025-05-23 | Frohlich Mark W | Buy | 1.25K | — | — |
| 2025-03-17 | Schorno Dean L | Buy | 7.85K | $12.70 | 99.69K |
| 2025-03-17 | Schorno Dean L | Buy | 5.62K | $35.40 | 199.12K |
| 2025-03-17 | Santos David A | Buy | 7.85K | $12.70 | 99.69K |
| 2025-03-17 | Santos David A | Buy | 6.88K | $35.40 | 243.38K |
| 2025-03-17 | Rojkjaer Lisa | Buy | 9.38K | $14.90 | 139.69K |
| 2025-03-17 | RODRIGUEZ RAUL R | Buy | 30.00K | $12.70 | 381.00K |
| 2025-03-17 | RODRIGUEZ RAUL R | Buy | 26.25K | $35.40 | 929.25K |
| 2025-03-17 | Furey Raymond J. | Buy | 9.38K | $9.00 | 84.38K |
| 2025-03-17 | Furey Raymond J. | Buy | 7.85K | $12.70 | 99.69K |
| 2025-03-06 | Frohlich Mark W | Buy | 12.00K | $19.70 | 236.40K |
| 2025-03-06 | Frohlich Mark W | Other | 0 | — | — |
| 2025-02-05 | Schorno Dean L | Sell | 1.73K | $21.93 | 38.02K |
| 2025-02-05 | Santos David A | Sell | 1.80K | $21.93 | 39.38K |
| 2025-02-05 | RODRIGUEZ RAUL R | Sell | 4.40K | $21.93 | 96.47K |
| 2025-02-05 | Furey Raymond J. | Sell | 1.34K | $21.93 | 29.36K |
Latest filed quarter: Q2 2026.
Institutions holding: 161, holders +6 vs prior quarter. Ownership 89.82%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 1.94M | 170.91K | +9.66% | 75.89M |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.84M | 1.84M | New | 72.12M |
| ARMISTICE CAPITAL, LLC | 1.67M | 392.00K | +30.63% | 65.41M |
| STATE STREET CORP | 1.04M | -80.24K | -7.16% | 40.68M |
| VANGUARD CAPITAL MANAGEMENT LLC | 785.11K | 20.91K | +2.74% | 30.71M |
| AMERICAN CENTURY COMPANIES INC | 741.72K | 197.29K | +36.24% | 29.02M |
| LSV ASSET MANAGEMENT | 721.67K | 120.16K | +19.98% | 28.23M |
| ACADIAN ASSET MANAGEMENT LLC | 591.69K | -74.74K | -11.22% | 23.14M |
| D. E. SHAW & CO., INC. | 542.54K | 96.86K | +21.73% | 21.22M |
| GEODE CAPITAL MANAGEMENT, LLC | 483.18K | 42.55K | +9.66% | 18.91M |
| MARSHALL WACE, LLP | 367.39K | -230.99K | -38.60% | 14.37M |
| CM MANAGEMENT, LLC | 250.00K | 15.00K | +6.38% | 9.78M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 233.73K | 86.19K | +58.42% | 9.14M |
| DIMENSIONAL FUND ADVISORS LP | 227.95K | -151.59K | -39.94% | 8.92M |
| GOLDMAN SACHS GROUP INC | 226.78K | -212.32K | -48.35% | 8.87M |
| TWO SIGMA INVESTMENTS, LP | 207.58K | -198.23K | -48.85% | 8.12M |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 195.00K | 195.00K | New | 7.63M |
| MORGAN STANLEY | 186.05K | 87.18K | +88.18% | 7.28M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 154.63K | 154.63K | New | 6.05M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 154.63K | -22.22K | -12.57% | 6.05M |
| NORTHERN TRUST CORP | 146.38K | 11.81K | +8.78% | 5.73M |
| RENAISSANCE TECHNOLOGIES LLC | 145.85K | -192.59K | -56.91% | 5.71M |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 131.18K | 5.51K | +4.39% | 5.13M |
| AQR CAPITAL MANAGEMENT LLC | 124.80K | 33.79K | +37.13% | 4.88M |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 124.18K | 124.18K | New | 4.86M |
Rigel Pharmaceuticals, Inc. (RIGL) trades at $50.75, with a market cap of $948.09M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$948.09M
Market Cap
—
P/E
—
Forward P/E
—
Score